Home Cart 0 Sign in  
X

[ CAS No. 55314-16-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 55314-16-4
Chemical Structure| 55314-16-4
Chemical Structure| 55314-16-4
Structure of 55314-16-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 55314-16-4 ]

Related Doc. of [ 55314-16-4 ]

Alternatived Products of [ 55314-16-4 ]

Product Details of [ 55314-16-4 ]

CAS No. :55314-16-4 MDL No. :MFCD00115180
Formula : C10H12N2O Boiling Point : -
Linear Structure Formula :- InChI Key :MZLRFUCMBQWLNV-FNORWQNLSA-N
M.W : 176.22 Pubchem ID :5369165
Synonyms :

Calculated chemistry of [ 55314-16-4 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.2
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 51.27
TPSA : 33.2 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.76 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.81
Log Po/w (XLOGP3) : 0.86
Log Po/w (WLOGP) : 1.34
Log Po/w (MLOGP) : 0.12
Log Po/w (SILICOS-IT) : 1.27
Consensus Log Po/w : 1.08

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.62
Solubility : 4.25 mg/ml ; 0.0241 mol/l
Class : Very soluble
Log S (Ali) : -1.14
Solubility : 12.7 mg/ml ; 0.0723 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.17
Solubility : 1.19 mg/ml ; 0.00675 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.1

Safety of [ 55314-16-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 55314-16-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 55314-16-4 ]
  • Downstream synthetic route of [ 55314-16-4 ]

[ 55314-16-4 ] Synthesis Path-Upstream   1~17

  • 1
  • [ 350-03-8 ]
  • [ 55314-16-4 ]
  • [ 4637-24-5 ]
Reference: [1] Patent: US4374988, 1983, A,
  • 2
  • [ 506-93-4 ]
  • [ 55314-16-4 ]
  • [ 66521-66-2 ]
YieldReaction ConditionsOperation in experiment
85% With sodium hydroxide In butan-1-ol for 16 h; Reflux 3-(Dimethylamino)-1-(pyridine-3-yl) prop-2-en-1-one (15.4 g, 0.088 mol), guanidine nitrate (10.7 g, 0.088 mol), and sodium hydroxide (3.5 g, 0.088 mol) were dissolved in n-butanol (120 mL).
The mixture was heated to reflux with stirring and maintained for 16 hours.
The reaction mixture was then cooled to room temperature.
The solid was collected and washed with water (400 mL).
The desired product was dried under vacuum for three days and 12.7 g of yellow crystals of desired product was obtained (yield: 85percent); 1H NMR (500 MHz, CDCl3) δ 5.15 (br., 2H), 7.09 (d, 1H), 7.44 (in, 1H), 8.33 (d, 1H), 8.42 (d, 1H), 8.73 (d, 1H), 9.22 (s, 1H). LC-MS (m/z) calculated, 172.2, found 173.2 [M+H]+.
1.18 g With sodium hydroxide In butan-1-ol at 90℃; for 0.333333 h; Microwave irradiation The obtained compound 3 followed by 3-(dimethylamino)-1-(pyridin-3-yl) prop-2-en-1-one (0.1 mol), guanidine nitrate(0.1 mol), sodium hydroxide (0.1 mol), and n-butanol (12.5 mL) was irradiated in the microwave synthesizer at 90 C for 20 min. Aftercompletion of the reaction mixture poured into ice-cold water andthe resulting solid was filtered and washed with water. The obtainedsolid of compound 4 (1.18 g) was dried under vacuum.Melting point 190-192 °C, ES-MS (M1) found (m/z): 173.1.
Reference: [1] Organic Process Research and Development, 2008, vol. 12, # 3, p. 490 - 495
[2] Patent: US9095622, 2015, B2, . Location in patent: Page/Page column 31
[3] Chemical Communications, 2010, vol. 46, # 14, p. 2450 - 2452
[4] Synlett, 2016, vol. 27, # 15, p. 2233 - 2236
[5] European Journal of Medicinal Chemistry, 2017, vol. 128, p. 1 - 12
[6] Journal of Molecular Structure, 2018, vol. 1171, p. 541 - 550
  • 3
  • [ 593-85-1 ]
  • [ 55314-16-4 ]
  • [ 66521-66-2 ]
YieldReaction ConditionsOperation in experiment
66% With sodium hydroxide In butan-1-ol at 120℃; for 2 h; NaOH (0.78 g, 19.5 mmol) was added to a mixture of 3-(dimethylamino)-l-(pyridin-3- yl)prop-2-en-l-one (3.52 g, 20.0 mmol) and guanidine carbonate (1.80 g) in n-butanol (20 mL). The mixture was heated at 1200C for 2 h. After cooling, the precipitates formed was collected by filtration and dried under vacuum to afford the desired product (2.3g, 66percent). LCMS: (M+H)+= 173.2.
Reference: [1] Patent: WO2010/96395, 2010, A1, . Location in patent: Page/Page column 36
[2] Patent: WO2008/130944, 2008, A1, . Location in patent: Page/Page column 15-16
  • 4
  • [ 50-01-1 ]
  • [ 55314-16-4 ]
  • [ 66521-66-2 ]
Reference: [1] RSC Advances, 2016, vol. 6, # 66, p. 61458 - 61467
[2] MedChemComm, 2015, vol. 6, # 10, p. 1816 - 1825
[3] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 11, p. 3860 - 3874
[4] Organic and Biomolecular Chemistry, 2009, vol. 7, # 24, p. 5129 - 5136
[5] Chemical Communications, 2010, vol. 46, # 7, p. 1118 - 1120
[6] Journal of the American Chemical Society, 2012, vol. 134, # 1, p. 700 - 706
[7] Journal of Heterocyclic Chemistry, 2015, vol. 52, # 5, p. 1296 - 1301
[8] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 15, p. 3714 - 3718
[9] Journal of Organic Chemistry, 2016, vol. 81, # 23, p. 11788 - 11801
[10] Archiv der Pharmazie, 2017, vol. 350, # 3-4,
  • 5
  • [ 506-93-4 ]
  • [ 55314-16-4 ]
  • [ 66521-66-2 ]
YieldReaction ConditionsOperation in experiment
93% for 12 h; Reflux General procedure: A mixture of compound 5 (1 mmol), guanidine nitrate (2 mmol), anhydrous K2CO3 (5 mmol) in n-butanol (10 ml) was refluxed for 12 h. After cooling, the solution was poured into H2O (30 ml) and then extracted with ethyl acetate (3x20 ml). The combined organic layer was concentrated in vacuo and then purified by recrystallisation with diethyl ether.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 13, p. 3024 - 3028
[2] Angewandte Chemie, International Edition, 2015, vol. 54, # 1, p. 179 - 183[3] Angewandte Chemie, 2015, vol. 127, # 1, p. 181 - 185,5
[4] Organic and Biomolecular Chemistry, 2013, vol. 11, # 11, p. 1822 - 1839
  • 6
  • [ 55314-16-4 ]
  • [ 66521-66-2 ]
Reference: [1] Russian Journal of Organic Chemistry, 2011, vol. 47, # 8, p. 1222 - 1226
[2] Angewandte Chemie - International Edition, 2013, vol. 52, # 33, p. 8551 - 8556[3] Angew. Chem., 2013, vol. 125, # 33, p. 8713 - 8718,6
[4] Synthesis, 2007, # 14, p. 2121 - 2124
[5] Russian Journal of Organic Chemistry, 2011, vol. 47, # 8, p. 1222 - 1226
[6] Russian Journal of Organic Chemistry, 2011, vol. 47, # 8, p. 1222 - 1226
  • 7
  • [ 420-04-2 ]
  • [ 55314-16-4 ]
  • [ 88-74-4 ]
  • [ 66521-66-2 ]
Reference: [1] Russian Journal of Organic Chemistry, 2011, vol. 47, # 8, p. 1222 - 1226
  • 8
  • [ 55314-16-4 ]
  • [ 66521-66-2 ]
Reference: [1] ChemMedChem, 2011, vol. 6, # 11, p. 2009 - 2018
  • 9
  • [ 50-01-1 ]
  • [ 55314-16-4 ]
  • [ 66521-66-2 ]
Reference: [1] Molecules, 2008, vol. 13, # 4, p. 818 - 830
  • 10
  • [ 55314-16-4 ]
  • [ 483324-01-2 ]
Reference: [1] Patent: CN105801559, 2016, A,
  • 11
  • [ 55314-16-4 ]
  • [ 404844-11-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 1, p. 249 - 255
[2] Organic Process Research and Development, 2008, vol. 12, # 3, p. 490 - 495
[3] Patent: US9095622, 2015, B2,
  • 12
  • [ 55314-16-4 ]
  • [ 404844-11-7 ]
Reference: [1] Angewandte Chemie, International Edition, 2015, vol. 54, # 1, p. 179 - 183[2] Angewandte Chemie, 2015, vol. 127, # 1, p. 181 - 185,5
  • 13
  • [ 1025716-99-7 ]
  • [ 55314-16-4 ]
  • [ 641569-94-0 ]
YieldReaction ConditionsOperation in experiment
8.7 g
Stage #1: With sodium hydroxide In butan-1-ol for 12 h; Inert atmosphere; Reflux
Stage #2: With water; sodium hydroxide In butan-1-ol at 25 - 125℃; for 0.333333 h;
Stage #3: With hydrogenchloride In water; butan-1-ol at 25 - 35℃; for 1 h;
3- [(Aminoiminomethyl)amino] -4-methyl-benzoic acid methylester mononitrate (10 g),3-(Dimethylamino)-1-(pyridine-3-yl)prop-2-en-1-one (7.3 g), sodium hydroxide (1.7 g) was added to 1-butanol (100 mL) in a round bottom flask under nitrogen atmosphere. The reaction mass was heated to reflux temperature and stirred for 12 his. Then the reaction mass was cooled to 25-35°C and iN sodium hydroxide solution (1.5 g in 37 mLof DM wter) was added to it over a period of 20 mm. The reaction mass was heated to reflux temperature (120-125°C) and then cooled to 25-35°C. iN hydrochloric acid. (3.3 mL in 37 mL of DM water) was added to the reaction mass at 25-35°C and stirred for an hour. The material formed was filtred, washed with DM water’ and then dried under vacuum at 50-55°C to provide the title compound (8.7 g).
Reference: [1] Patent: WO2015/87343, 2015, A2, . Location in patent: Page/Page column 15
  • 14
  • [ 1207534-99-3 ]
  • [ 55314-16-4 ]
  • [ 641569-94-0 ]
Reference: [1] RSC Advances, 2016, vol. 6, # 66, p. 61458 - 61467
  • 15
  • [ 1025716-98-6 ]
  • [ 55314-16-4 ]
  • [ 641569-94-0 ]
  • [ 917392-54-2 ]
Reference: [1] Patent: US2008/300268, 2008, A1, . Location in patent: Page/Page column 59-60
  • 16
  • [ 55314-16-4 ]
  • [ 641569-94-0 ]
Reference: [1] Patent: WO2008/137770, 2008, A1,
[2] Patent: WO2008/137605, 2008, A1,
  • 17
  • [ 55314-16-4 ]
  • [ 726169-73-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 15, p. 6156 - 6174
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 55314-16-4 ]

Nilotinib Related Intermediates

Chemical Structure| 641569-97-3

[ 641569-97-3 ]

Ethyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate

Chemical Structure| 641571-11-1

[ 641571-11-1 ]

3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline

Chemical Structure| 96-98-0

[ 96-98-0 ]

4-Methyl-3-nitrobenzoic acid

Chemical Structure| 54962-75-3

[ 54962-75-3 ]

3-Bromo-5-(trifluoromethyl)aniline

Chemical Structure| 66521-66-2

[ 66521-66-2 ]

4-(Pyridin-3-yl)pyrimidin-2-amine

Related Functional Groups of
[ 55314-16-4 ]

Alkenes

Chemical Structure| 1201-93-0

[ 1201-93-0 ]

3-(Dimethylamino)-1-phenyl-2-propen-1-one

Similarity: 0.66

Chemical Structure| 5337-79-1

[ 5337-79-1 ]

3-(Pyridin-4-yl)acrylic acid

Similarity: 0.59

Chemical Structure| 74173-48-1

[ 74173-48-1 ]

4-Methyl-4'-vinyl-2,2'-bipyridine

Similarity: 0.58

Chemical Structure| 1126-74-5

[ 1126-74-5 ]

3-(Pyridin-3-yl)acrylic acid

Similarity: 0.58

Chemical Structure| 19337-97-4

[ 19337-97-4 ]

trans-3-(3-Pyridyl)acrylic acid

Similarity: 0.58

Ketones

Chemical Structure| 35779-35-2

[ 35779-35-2 ]

Di(pyridin-3-yl)methanone

Similarity: 0.86

Chemical Structure| 1570-48-5

[ 1570-48-5 ]

1-(Pyridin-3-yl)propan-1-one

Similarity: 0.84

Chemical Structure| 350-03-8

[ 350-03-8 ]

1-(Pyridin-3-yl)ethanone

Similarity: 0.84

Chemical Structure| 1701-70-8

[ 1701-70-8 ]

1-(Pyridin-3-yl)butan-1-one

Similarity: 0.83

Chemical Structure| 51907-18-7

[ 51907-18-7 ]

5H-Cyclopenta[c]pyridin-7(6H)-one

Similarity: 0.81

Amines

Chemical Structure| 1187930-07-9

[ 1187930-07-9 ]

4-Amino-1-(pyridin-3-yl)butan-1-one dihydrochloride

Similarity: 0.77

Chemical Structure| 19828-20-7

[ 19828-20-7 ]

2-Amino-5-acetylpyridine

Similarity: 0.75

Chemical Structure| 65326-33-2

[ 65326-33-2 ]

1-(2-Aminopyridin-3-yl)ethanone

Similarity: 0.67

Chemical Structure| 1201-93-0

[ 1201-93-0 ]

3-(Dimethylamino)-1-phenyl-2-propen-1-one

Similarity: 0.66

Chemical Structure| 42182-25-2

[ 42182-25-2 ]

1-(2-Aminopyridin-4-yl)ethanone

Similarity: 0.66

Related Parent Nucleus of
[ 55314-16-4 ]

Pyridines

Chemical Structure| 35779-35-2

[ 35779-35-2 ]

Di(pyridin-3-yl)methanone

Similarity: 0.86

Chemical Structure| 1570-48-5

[ 1570-48-5 ]

1-(Pyridin-3-yl)propan-1-one

Similarity: 0.84

Chemical Structure| 350-03-8

[ 350-03-8 ]

1-(Pyridin-3-yl)ethanone

Similarity: 0.84

Chemical Structure| 1701-70-8

[ 1701-70-8 ]

1-(Pyridin-3-yl)butan-1-one

Similarity: 0.83

Chemical Structure| 5424-19-1

[ 5424-19-1 ]

Phenyl(pyridin-3-yl)methanone

Similarity: 0.81